BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

265 related articles for article (PubMed ID: 29489406)

  • 1. Utility of Pelvic CT for Surveillance of T2-T4 Renal Cell Carcinoma After Nephrectomy With Curative Intent.
    Kaiser A; Davenport MS; Hafez KS; Alva A; Bailey JJ; Francis IR
    AJR Am J Roentgenol; 2018 May; 210(5):1088-1091. PubMed ID: 29489406
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Renal cell carcinoma: evaluation of the 1997 TNM system and recommendations for follow-up after surgery.
    Gofrit ON; Shapiro A; Kovalski N; Landau EH; Shenfeld OZ; Pode D
    Eur Urol; 2001 Jun; 39(6):669-74; discussion 675. PubMed ID: 11464056
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Is there a need for pelvic CT scan in cases of renal cell carcinoma?
    Khaitan A; Gupta NP; Hemal AK; Dogra PN; Seth A; Aron M
    Int Urol Nephrol; 2002; 33(1):13-5. PubMed ID: 12090319
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Is adrenalectomy a necessary component of radical nephrectomy? UCLA experience with 511 radical nephrectomies.
    Tsui KH; Shvarts O; Barbaric Z; Figlin R; de Kernion JB; Belldegrun A
    J Urol; 2000 Feb; 163(2):437-41. PubMed ID: 10647649
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Axial Abdominal Imaging after Partial Nephrectomy for T1 Renal Cell Carcinoma Surveillance.
    Sorokin I; Canvasser NE; Margulis V; Lotan Y; Raj G; Sagalowsky A; Gahan JC; Cadeddu JA
    J Urol; 2017 Nov; 198(5):1021-1026. PubMed ID: 28442383
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Radiologic follow-up of patients with T1-3a,b,c or T4N+M0 renal cell carcinoma after radical nephrectomy.
    Saidi JA; Newhouse JH; Sawczuk IS
    Urology; 1998 Dec; 52(6):1000-3. PubMed ID: 9836544
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Usefulness of Chest X-Rays for T1a Renal Cell Carcinoma Surveillance.
    Canvasser NE; Stouder K; Lay AH; Gahan JC; Lotan Y; Margulis V; Raj GV; Sagalowsky AI; Cadeddu JA
    J Urol; 2016 Aug; 196(2):321-6. PubMed ID: 26880407
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Staging of 119 patients with renal cell carcinoma: the yield and cost-effectiveness of pelvic CT.
    Fielding JR; Aliabadi N; Renshaw AA; Silverman SG
    AJR Am J Roentgenol; 1999 Jan; 172(1):23-5. PubMed ID: 9888732
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Outcome of isolated renal cell carcinoma fossa recurrence after nephrectomy.
    Itano NB; Blute ML; Spotts B; Zincke H
    J Urol; 2000 Aug; 164(2):322-5. PubMed ID: 10893575
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Limited use of surveillance imaging following nephrectomy for renal cell carcinoma.
    Kim EH; Vetter JM; Kuxhausen AN; Song JB; Sandhu GS; Strope SA
    Urol Oncol; 2016 May; 34(5):237.e11-8. PubMed ID: 26725251
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Should We Separate the Pulmonary Surveillance Protocol for Postsurgical T1a and T1b Renal Cell Carcinoma? A Multicenter Database Analysis.
    Chow AK; Kahan AN; Hwang T; Coogan CL; Latchamsetty KC
    Urology; 2018 Dec; 122():127-132. PubMed ID: 30205104
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The blind spots in follow-up after nephrectomy or nephron-sparing surgery for localized renal cell carcinoma.
    van Oostenbrugge TJ; Kroeze SG; Bosch JL; van Melick HH
    World J Urol; 2015 Jun; 33(6):881-7. PubMed ID: 25179013
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Stage specific guidelines for surveillance after radical nephrectomy for local renal cell carcinoma.
    Levy DA; Slaton JW; Swanson DA; Dinney CP
    J Urol; 1998 Apr; 159(4):1163-7. PubMed ID: 9507823
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Renal pelvic recurrence of renal cell carcinoma.
    Smith RM; Wolf JS
    Urology; 2012 Oct; 80(4):e33-4. PubMed ID: 22921699
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Image-Guided Thermal Ablation for Non-resectable Recurrence of Renal Cell Cancer Following Nephrectomy: Clinical Experience with Eleven Patients.
    Zhou W; Herwald SE; Uppot RN; Arellano RS
    Cardiovasc Intervent Radiol; 2018 Nov; 41(11):1743-1750. PubMed ID: 29721615
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Is Extensive Parenchymal Resection During Robotic Partial Nephrectomy Justified? A Match-Paired Comparison of Two Extirpative Surgical Modalities for Treatment of a Complex Renal Neoplasm.
    Andrade HS; Zargar H; Akca O; Caputo PA; Ramirez D; Kara O; Stein RJ; Chueh SC; Kaouk JH
    J Endourol; 2016 Apr; 30(4):379-83. PubMed ID: 26486995
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Patterns of Relapse and Implications for Post-Nephrectomy Surveillance in Patients with High Risk Nonclear Cell Renal Cell Carcinoma: Subgroup Analysis of the Phase 3 ECOG-ACRIN E2805 Trial.
    Narayan V; Puligandla M; Haas NB; Subramanian P; DiPaola RS; Uzzo R
    J Urol; 2019 Jan; 201(1):62-68. PubMed ID: 30130544
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Diagnostic radiation exposure during surveillance in patients with pT1a renal cell carcinoma.
    Lipsky MJ; Shapiro EY; Hruby GW; McKiernan JM
    Urology; 2013 Jun; 81(6):1190-5. PubMed ID: 23540857
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Is Chest Computed Tomography Always Necessary Following Nephrectomy for Renal Cell Carcinoma? A Pilot Study in Single Tertiary Institution.
    Lee HS; Kang WJ; Cho NH; Park SY
    J Comput Assist Tomogr; 2019; 43(2):333-337. PubMed ID: 30875337
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Local recurrence and metastatic dissemination of renal cell carcinoma: clinical and imaging characteristics].
    Mignon F; Mesurolle B
    J Radiol; 2003 Mar; 84(3):275-84. PubMed ID: 12736586
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.